{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T12:30:35Z","timestamp":1655728235834},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T00:00:00Z","timestamp":1402185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T00:00:00Z","timestamp":1402185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12029-014-9626-7","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T22:47:03Z","timestamp":1402440423000},"page":"198-200","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cetuximab in Refractory Squamous Cell Carcinoma of the Anal Canal"],"prefix":"10.1007","volume":"45","author":[{"given":"Jane E.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,8]]},"reference":[{"issue":"1","key":"9626_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"9626_CR2","unstructured":"National Comprehensive Cancer Center Network. Anal Carcinoma. Version 2.2014. Accessed 3\/20\/14."},{"key":"9626_CR3","first-page":"161","volume":"3","author":"NN Silva","year":"2012","unstructured":"Silva NN, Eng C. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy. J Adv Pract Oncol. 2012;3:161\u20139.","journal-title":"J Adv Pract Oncol"},{"issue":"10","key":"9626_CR4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1586\/era.09.113","volume":"9","author":"F Rivera","year":"2009","unstructured":"Rivera F, Garcia-Castano A, Vega N, et al. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial. Expert Rev Anticancer Ther. 2009;9(10):1421\u20138.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9674","key":"9626_CR5","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(09)60569-9","volume":"373","author":"R Pirker","year":"2009","unstructured":"Pirker R, Pereira JR, Szczesna A, et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomized phase III trial. Lancet. 2009;373(9674):1525\u201331.","journal-title":"Lancet"},{"issue":"1","key":"9626_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00280-009-1117-3","volume":"65","author":"MG Zampino","year":"2009","unstructured":"Zampino MG, Magni E, Sonzogni A, et al. K-ras status in squamous cell anal carcinoma (SCC): it\u2019s time for target-oriented treatment? Cancer Chemother Pharmacol. 2009;65(1):197\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"9626_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1309\/X4UADHVN317V2XMW","volume":"124","author":"LH Le","year":"2005","unstructured":"Le LH, Chetty R, Moore MJ. Epidermal growth factor receptor expression in anal canal carcinoma. Am J Clin Pathol. 2005;124(1):20\u20133.","journal-title":"Am J Clin Pathol"},{"key":"9626_CR8","doi-asserted-by":"crossref","unstructured":"Casadei Gardini A, Capelli L, Ulivi P, et al. KRAS, BRAF, and PIK3CA status in squamous cell anal carcinoma (SCAC). PLos One. 2014; 9 (3).","DOI":"10.1371\/journal.pone.0092071"},{"key":"9626_CR9","unstructured":"Erbitux (cetuximab) injection package insert. Princeton, NJ:Bristol-Myers Squibb Company;2013."},{"issue":"3","key":"9626_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000355004","volume":"6","author":"E Klimant","year":"2013","unstructured":"Klimant E, Markman M. Management of two cases of recurrent anal carcinoma. Case Rep Oncol. 2013;6(3):456\u201361.","journal-title":"Case Rep Oncol"},{"issue":"2","key":"9626_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1159\/000341371","volume":"5","author":"H Barmettler","year":"2012","unstructured":"Barmettler H, Komminoth P, Schmid M, et al. Efficacy of cetuximab in combination with FOLFIRI in a patient with KRAS-wild type metastatic anal cancer. Case Rep Oncol. 2012;5(2):428\u201333.","journal-title":"Case Rep Oncol"},{"issue":"3","key":"9626_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10350-006-0786-9","volume":"50","author":"LK Phan","year":"2007","unstructured":"Phan LK, Hoff PM. Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: a report of a case. Dis Colon Rectum. 2007;50(3):395\u20138.","journal-title":"Dis Colon Rectum"},{"key":"9626_CR13","doi-asserted-by":"crossref","unstructured":"Saif MW, Kontny E, Syrigos KN, et al. The role of EGFR inhibitors in the treatment of metastatic anal canal carcinoma: a case series. J Oncol. 2011; 2011: 125467","DOI":"10.1155\/2011\/125467"},{"issue":"5","key":"9626_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000259615","volume":"77","author":"N Lukan","year":"2009","unstructured":"Lukan N, Strobel P, Willer A, et al. Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status. Oncology. 2009;77(5):293\u20139.","journal-title":"Oncology"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9626-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-014-9626-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9626-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-014-9626-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T10:55:29Z","timestamp":1628592929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-014-9626-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,8]]},"references-count":14,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9626"],"URL":"https:\/\/doi.org\/10.1007\/s12029-014-9626-7","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,8]]},"assertion":[{"value":"8 June 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}